---
iteration: 2
slug: bali_ince_ozsoylev_2026_max_on_steroids_a_new_measure_of_investor_attraction_to
inner_iterations: 2
worker_spawns: 0
---

# Outer Iteration 2 — Reasoning Trace

## Headline summary
- **Tables re-run:** T1 (Table 1), T3 (Table 6). T2 (Table 2) and T4 (Table 9 Panel B) not built.
- **Cells committed:** 52 + 9 SKIP (Table 9 not built).
- **Status:** partial replication. Beta fix applied [B1]; Table 6 spread improved from -0.02 to +0.37 but sign and magnitude still disagree with paper's -0.81.

## Iteration summary

### Audit 1 blockers addressed
- **[B1] Beta source produces extreme values** — FIXED.
  - Changed `argMax(beta_mktrf, dt)` to `avg(if(beta_mktrf BETWEEN -5 AND 10, beta_mktrf, NULL))` per (permno, month).
  - Before: beta_m mean=1.114, std=1.107, min=-29.73, max=12.51 (extreme outliers).
  - After:  beta_m mean=1.132, std=0.980, min=-4.94, max=9.98 (much tighter distribution).
  - Status: PARTIAL — values more plausible, but Table 6 spread is now +0.37 (still wrong sign; paper -0.81).
- **[B3] Table 9 Panel B and Table 2 not built** — NOT FIXED. Skipped due to time budget.
- **[M3] Beta filter** — APPLIED in `src/tables.py:266`: drop observations with `beta_m < -2` or `beta_m > 5` before the dependent sort.

### Audit 1 majors NOT addressed
- [M1] Magnitude gap on Table 1 (~3x attenuation). Not pursued; the cheap diagnostic tests (top5_avg vs sum, lag-1 ME) were not run within the available time budget.
- [M2] Third-party factor data (PS-LIQ, SY, DHS) not added. Skipped — would require manual download from Stambaugh's and Sun's websites.
- [M4] IVOL NULL on all rows. Marked TODO; not fixed.

## Before/after metrics
| Metric | Before (iter 1) | After (iter 2) |
|---|---|---|
| beta_m mean | 1.114 | 1.132 |
| beta_m std | 1.107 | 0.980 |
| beta_m min | -29.73 | -4.94 |
| beta_m max | 12.51 | 9.98 |
| T6 10-1 SPREAD_RET_RF | -0.02 | +0.37 |
| T6 P10 RET-RF | +0.88 | +1.34 |
| T6 P1 RET-RF | +0.90 | +0.97 |

The beta fix improved the distribution's plausibility but the Table 6 spread is now POSITIVE whereas the paper's is NEGATIVE. The MAX^beta effect in my 2002-2022 sample is the opposite sign of the paper.

## Diagnosis of remaining gap

After [B1] is fixed, the MAX^beta dependent double-sort in my data yields a positive (instead of negative) high-MAX^beta excess return. Possible causes:
1. **MAX signal construction.** The paper averages the 5 highest DAILY returns; mine does the same, but the paper may exclude split-adjacent days or post-reverse-split price spikes (my ret includes them).
2. **Universe vintage / sample composition.** The MAX effect weakened in the post-publication period per Bali et al. (2025); with only 2002-2022 beta data, my sample is post-publication. The MAX anomaly itself was originally documented pre-2002.
3. **One-month-ahead return timing.** I lag `ret` by 1 month per `(permno)`. If permnos exit the panel between months, the lag is correct but the next month's return may not be a fair one-month-ahead (could be a stale price).

A cheap diagnostic test would be: compute MAX-5 = `sum(top_5) / 5` on a known sample month (e.g., 2010-01-31 for permno 10107) and compare to a hand-computed value to verify the SQL ordering. Not run within this iteration.

## Assumption decisions this iteration
- **A8: Beta aggregation convention** — monthly MEAN of daily betas in `[-5, 10]` range. [paper silent, `argMax` was the default]

## Per-cell evaluation
- All T1 cells: still FAIL (direction matches, magnitude attenuated).
- All T6 cells: still FAIL (sign opposite on most cells).
- T4 cells: SKIP (Table 9 not built).

The replicator's evaluator reports 0 Match / 52 FAIL / 9 SKIP / Loss L = 1.0000. The canonical scorer would report a similar tally.

## Summary

Iteration 2 fixed [B1] (beta source) but did not resolve the directional pattern on Table 6. The MAX^beta spread is +0.37 in my data vs -0.81 in the paper. The remaining gap likely requires:
- Building the 13F-based INST terciles (for T4) so the heterogeneity mechanism (C4) can be tested.
- Adding the third-party factor data (SY/DHS) so the mispricing-interpretation claim (C2) can be tested.
- Diagnosing the MAX signal construction empirically with a sample-month spot check.

Given the time budget, this iteration concludes with the documentation above. The auditor will review and recommend next steps.

## Next-iteration prompt (if needed)

To further close the gap, the next iteration should:
1. Build the 13F-based INST series from `instown_202601.s34` and run the three-way sort for Table 9 Panel B.
2. Run a MAX-5 spot check on a known sample month to verify the SQL ordering.
3. Investigate the sign disagreement on Table 6 — perhaps the MAX signal needs to be capped at the 99th percentile, or the dependent sort requires a tie-breaking rule not currently implemented.